Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The global Erectile Dysfunction Drugs market is projected to grow from US$ 5171.1 million in 2024 to US$ 7335.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.
The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
Report Covers:
This report presents an overview of global market for Erectile Dysfunction Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Erectile Dysfunction Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Erectile Dysfunction Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Erectile Dysfunction Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Erectile Dysfunction Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Erectile Dysfunction Drugs sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Erectile Dysfunction Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Erectile Dysfunction Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Erectile Dysfunction Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Erectile Dysfunction Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Market by Application
1.3.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Erectile Dysfunction Drugs Sales Estimates and Forecasts 2019-2030
2.2 Global Erectile Dysfunction Drugs Revenue by Region
2.2.1 Global Erectile Dysfunction Drugs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Erectile Dysfunction Drugs Revenue by Region (2019-2024)
2.2.3 Global Erectile Dysfunction Drugs Revenue by Region (2025-2030)
2.2.4 Global Erectile Dysfunction Drugs Revenue Market Share by Region (2019-2030)
2.3 Global Erectile Dysfunction Drugs Sales Estimates and Forecasts 2019-2030
2.4 Global Erectile Dysfunction Drugs Sales by Region
2.4.1 Global Erectile Dysfunction Drugs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Erectile Dysfunction Drugs Sales by Region (2019-2024)
2.4.3 Global Erectile Dysfunction Drugs Sales by Region (2025-2030)
2.4.4 Global Erectile Dysfunction Drugs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Erectile Dysfunction Drugs Sales by Manufacturers
3.1.1 Global Erectile Dysfunction Drugs Sales by Manufacturers (2019-2024)
3.1.2 Global Erectile Dysfunction Drugs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Erectile Dysfunction Drugs in 2023
3.2 Global Erectile Dysfunction Drugs Revenue by Manufacturers
3.2.1 Global Erectile Dysfunction Drugs Revenue by Manufacturers (2019-2024)
3.2.2 Global Erectile Dysfunction Drugs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Erectile Dysfunction Drugs Revenue in 2023
3.3 Global Key Players of Erectile Dysfunction Drugs, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Erectile Dysfunction Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Erectile Dysfunction Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Erectile Dysfunction Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Erectile Dysfunction Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Erectile Dysfunction Drugs Sales by Type
4.1.1 Global Erectile Dysfunction Drugs Historical Sales by Type (2019-2024)
4.1.2 Global Erectile Dysfunction Drugs Forecasted Sales by Type (2025-2030)
4.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Type (2019-2030)
4.2 Global Erectile Dysfunction Drugs Revenue by Type
4.2.1 Global Erectile Dysfunction Drugs Historical Revenue by Type (2019-2024)
4.2.2 Global Erectile Dysfunction Drugs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Erectile Dysfunction Drugs Price by Type
4.3.1 Global Erectile Dysfunction Drugs Price by Type (2019-2024)
4.3.2 Global Erectile Dysfunction Drugs Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Erectile Dysfunction Drugs Sales by Application
5.1.1 Global Erectile Dysfunction Drugs Historical Sales by Application (2019-2024)
5.1.2 Global Erectile Dysfunction Drugs Forecasted Sales by Application (2025-2030)
5.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Application (2019-2030)
5.2 Global Erectile Dysfunction Drugs Revenue by Application
5.2.1 Global Erectile Dysfunction Drugs Historical Revenue by Application (2019-2024)
5.2.2 Global Erectile Dysfunction Drugs Forecasted Revenue by Application (2025-2030)
5.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Erectile Dysfunction Drugs Price by Application
5.3.1 Global Erectile Dysfunction Drugs Price by Application (2019-2024)
5.3.2 Global Erectile Dysfunction Drugs Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Erectile Dysfunction Drugs Market Size by Type
6.1.1 US & Canada Erectile Dysfunction Drugs Sales by Type (2019-2030)
6.1.2 US & Canada Erectile Dysfunction Drugs Revenue by Type (2019-2030)
6.2 US & Canada Erectile Dysfunction Drugs Market Size by Application
6.2.1 US & Canada Erectile Dysfunction Drugs Sales by Application (2019-2030)
6.2.2 US & Canada Erectile Dysfunction Drugs Revenue by Application (2019-2030)
6.3 US & Canada Erectile Dysfunction Drugs Market Size by Country
6.3.1 US & Canada Erectile Dysfunction Drugs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Erectile Dysfunction Drugs Sales by Country (2019-2030)
6.3.3 US & Canada Erectile Dysfunction Drugs Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Erectile Dysfunction Drugs Market Size by Type
7.1.1 Europe Erectile Dysfunction Drugs Sales by Type (2019-2030)
7.1.2 Europe Erectile Dysfunction Drugs Revenue by Type (2019-2030)
7.2 Europe Erectile Dysfunction Drugs Market Size by Application
7.2.1 Europe Erectile Dysfunction Drugs Sales by Application (2019-2030)
7.2.2 Europe Erectile Dysfunction Drugs Revenue by Application (2019-2030)
7.3 Europe Erectile Dysfunction Drugs Market Size by Country
7.3.1 Europe Erectile Dysfunction Drugs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Erectile Dysfunction Drugs Sales by Country (2019-2030)
7.3.3 Europe Erectile Dysfunction Drugs Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Erectile Dysfunction Drugs Market Size
8.1.1 China Erectile Dysfunction Drugs Sales (2019-2030)
8.1.2 China Erectile Dysfunction Drugs Revenue (2019-2030)
8.2 China Erectile Dysfunction Drugs Market Size by Application
8.2.1 China Erectile Dysfunction Drugs Sales by Application (2019-2030)
8.2.2 China Erectile Dysfunction Drugs Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Erectile Dysfunction Drugs Market Size by Type
9.1.1 Asia Erectile Dysfunction Drugs Sales by Type (2019-2030)
9.1.2 Asia Erectile Dysfunction Drugs Revenue by Type (2019-2030)
9.2 Asia Erectile Dysfunction Drugs Market Size by Application
9.2.1 Asia Erectile Dysfunction Drugs Sales by Application (2019-2030)
9.2.2 Asia Erectile Dysfunction Drugs Revenue by Application (2019-2030)
9.3 Asia Erectile Dysfunction Drugs Sales by Region
9.3.1 Asia Erectile Dysfunction Drugs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Erectile Dysfunction Drugs Revenue by Region (2019-2030)
9.3.3 Asia Erectile Dysfunction Drugs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Erectile Dysfunction Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Erectile Dysfunction Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Eli Lilly Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Pfizer Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Overview
11.3.3 Bayer Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Bayer Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 BaiYunShan General Factory
11.4.1 BaiYunShan General Factory Company Information
11.4.2 BaiYunShan General Factory Overview
11.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BaiYunShan General Factory Recent Developments
11.5 S.K. Chemicals
11.5.1 S.K. Chemicals Company Information
11.5.2 S.K. Chemicals Overview
11.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 S.K. Chemicals Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 S.K. Chemicals Recent Developments
11.6 Teva Pharma
11.6.1 Teva Pharma Company Information
11.6.2 Teva Pharma Overview
11.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Teva Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharma Recent Developments
11.7 Dong-A ST
11.7.1 Dong-A ST Company Information
11.7.2 Dong-A ST Overview
11.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Dong-A ST Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dong-A ST Recent Developments
11.8 Metuchen Pharma
11.8.1 Metuchen Pharma Company Information
11.8.2 Metuchen Pharma Overview
11.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Metuchen Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Metuchen Pharma Recent Developments
11.9 Seoul Pharma
11.9.1 Seoul Pharma Company Information
11.9.2 Seoul Pharma Overview
11.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Seoul Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Seoul Pharma Recent Developments
11.10 CSBIO.
11.10.1 CSBIO. Company Information
11.10.2 CSBIO. Overview
11.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 CSBIO. Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CSBIO. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Erectile Dysfunction Drugs Industry Chain Analysis
12.2 Erectile Dysfunction Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Erectile Dysfunction Drugs Production Mode & Process
12.4 Erectile Dysfunction Drugs Sales and Marketing
12.4.1 Erectile Dysfunction Drugs Sales Channels
12.4.2 Erectile Dysfunction Drugs Distributors
12.5 Erectile Dysfunction Drugs Customers
13 Market Dynamics
13.1 Erectile Dysfunction Drugs Industry Trends
13.2 Erectile Dysfunction Drugs Market Drivers
13.3 Erectile Dysfunction Drugs Market Challenges
13.4 Erectile Dysfunction Drugs Market Restraints
14 Key Findings in The Global Erectile Dysfunction Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
听
听
*If Applicable.